Skip to main content
Gideon A. Stitt

Gideon A. Stitt, PharmD, BCPPS, BCCCP

Languages spoken: English

Academic Information

Departments Primary - Pediatrics

Divisions: Clinical Pharmacology

Board Certification

  • Board of Pharmacy Specialties (Sub: Critical Care Pharmacy)

Education History

Certification University of Florida
Thomas Jefferson University
Postdoctoral Fellowship Children’s Hospital of Philadelphia
Postdoctoral Research Fellow
Boston Children’s Hospital
Residency Children’s Hospital of Philadelphia
Medical University of South Carolina College of Pharmacy
Undergraduate Clemson University

Selected Publications

Journal Article

  1. Stitt G, Spinella PC, Bochicchio GV, Roberts I, Downes KJ, Zuppa AF (2024). Population pharmacokinetic modelling and simulation of tranexamic acid in adult trauma patients. Br J Clin Pharmacol. (Read full article)
  2. Stitt G, Thibault, Mueller BA, Cies JJ, Daniel JM, Akcan-Arikan A, Watt KM (2024). Pharmacokinetic Research in Pediatric Extracorporeal Therapies: Current State and Future Directions. Blood Purif.
  3. Jain M, Stitt G, Son L, Enioutina E (2023). Probiotics and Their Bioproducts: A Promising Approach for Targeting Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus. Microorganisms, 11(10), 2393.
  4. Popenhagen MP, Genovese P, Blishen M, Rajapakse D, Diem A, King A, Chan J, Pellicer Arasa E, Baird S, Ferreira da Rocha AC, Stitt G, Badger K, Zmazek V, Ambreen F, Mackenzie C, Price H, Roberts T, Moore Z, Patton D, Murphy P, Mayre-Chilton K (2023). Consensus-based guidelines for the provision of palliative and end-of-life care for people living with epidermolysis bullosa. Orphanet J Rare Dis, 18(1), 268. (Read full article)
  5. Lewis SA, Shetty S, Gamble S, Heim J, Zhao N, Stitt G, Pankratz M, Mangum T, Marku I, Rosenberg RB, Wilfong AA, Fahey MC, Kim S, Myers SJ, Appavu B, Kruer MC (2023). Intrathecal magnesium delivery for Mg++-insensitive NMDA receptor activity due to GRIN1 mutation. Orphanet J Rare Dis, 18(1), 225. (Read full article)
  6. Stitt G, Dubinsky S, Edginton A, Huang YV, Zuppa AF, Watt K, Downes K (2022). Antimicrobial Dosing Recommendations in Pediatric Continuous Renal Replacement Therapy: A Critical Appraisal of Current Evidence. Front Pediatr, 10, 889958. (Read full article)
  7. Santiago JA, Babico M, Stitt G, Thomas CA, Desai S, Willard S, Swing T, Kruer MC (2021). Low-dose intrathecal rituximab is a safe and potentially effective treatment for pediatric neuroimmunologic disorders. J Neuroimmunol, 359, 577687. (Read full article)
  8. Stitt G, Morris J, Schmees L, Angelo J, Akcan Arikan A (2019). Cefepime Pharmacokinetics in Critically Ill Pediatric Patients Receiving Continuous Renal Replacement Therapy. Antimicrob Agents Chemother, 63(4). (Read full article)
  9. Moffett BS, Kam C, Galati M, Schmees L, Stitt GA, Revell PA, Palazzi DL (2018). The "Ideal" Body Weight for Pediatric Gentamicin Dosing in the Era of Obesity: A Population Pharmacokinetic Analysis. Ther Drug Monit, 40(3), 322-329. (Read full article)


  1. Pais GM, Chang J, Barreto EF, Stitt G, Downes KJ, Alshaer MH, Lesnicki E, Panchal V, Bruzzone M, Bumanglag AV, Burke SN, Scheetz MH (2022). Clinical Pharmacokinetics and Pharmacodynamics of Cefepime. [Review]. Clin Pharmacokinet, 61(7), 929-953. (Read full article)
  2. Stitt G, Normandin PA (2016). Part 1: Safe Administration of Oral Pediatric Medications in the Emergency Department. [Review]. J Emerg Nurs, 42(3), 276-8. (Read full article)